Top Markets
Coin of the day
Phoenix Life Sciences International Limited Phoenix Life Sciences International Limited

Phoenix Life Sciences International Limited

PLSI
Rang in Aktien #42848
Phoenix Life Sciences International Limited operates as a global healthcare... Phoenix Life Sciences International Limited operates as a global healthcare solutions provider, conducting business in the United States and internationally. The company primarily concentrates on pioneering research, developing integrated programs, and producing goods aimed at the prevention and treatment of a broad spectrum of conditions. These include diabetes, pain, and various cancers, as well as psychological, gastrointestinal, autoimmune, neurological, and sleep disorders. Its diverse product line encompasses oral soft gel capsules, thin film dissolvable strips, transdermal patches, sublingual oral sprays, suppositories, and topical creams. Established in 2009, the company was initially known as Stem Bioscience, Inc., before officially adopting the name Phoenix Life Sciences International Limited in May 2018. Its corporate headquarters are located in Las Vegas, Nevada.
Aktienkurs
$0.0001
Zuletzt synchronisiert: 2023-09-25
Marktkapitalisierung
$2.82
Veränderung (1 Tag)
0.00%
Veränderung (1 Jahr)
0.00%
Land
US
Handel Phoenix Life Sciences International Limited (PLSI)

Kategorie

EPS für Phoenix Life Sciences International Limited (PLSI)
EPS zum 2026 TTM: 0
Laut den aktuellen Finanzberichten und dem Aktienkurs von Phoenix Life Sciences International Limited beträgt das aktuelle EPS des Unternehmens (TTM) 0. Am Ende des Jahres 2026 betrug das EPS 0 gleich wie dem EPS von 2026, das 0 betrug.
EPS-Verlauf von Phoenix Life Sciences International Limited von 2026 bis 2026
EPS am Ende jedes Jahres
Jahr EPS ändert
Nicht genügend Daten für die angegebenen Daten.
EPS für ähnliche Unternehmen oder Wettbewerber